Clinical trials: Body Dysmorphic Disorder
Body Dysmorphic Disorders, Anorexia
Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study
The place of opioid system in anorexia nervosa (AN) physiopathology is still unclear. Conflicting results were published on cerebral spinal fluid or peripheral levels in anorexia nervosa.
- Trial name
- NCT02524301
- Testing
- Positron Emission Tomography using [11C]diprenorphine
- Where
- 3 sites in France
- Volunteers
- 53 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Anorexia
Body Image Disorder in Anorexia Nervosa and Virtual Reality
Evaluation of the tolerance and acceptability of the virtual representation of its body image.
- Trial name
- REVAM (NCT03118921)
- Testing
- Virtual reality
- Where
- France
- Volunteers
- 17 people
- Sponsor
- University Hospital, Brest
Body Dysmorphic Disorder, BDD
Internet Delivered CBT for Body Dysmorphic Disorder
To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.
- Trial name
- NCT02010619
- Testing
- Cognitive behavior therapy, Supportive therapy
- Where
- Sweden
- Volunteers
- 94 people
- Sponsor
- Karolinska Institutet
Obsessive Compulsive Disorder, Body Dysmorphic Disorder
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).
- Conditions
- Obsessive Compulsive Disorder, Body Dysmorphic Disorder, Tourette Syndrome, Trichotillomania
- Trial name
- NCT01075672
- Testing
- Cognitive behavioral therapy (CBT)
- Where
- United States
- Volunteers
- 250 people
- Sponsor
- Massachusetts General Hospital
Bulimia Nervosa, Body Dysmorphic Disorder
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from…
- Trial name
- NCT01038128
- Testing
- Memantine
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Mclean Hospital
Body Dysmorphic Disorder, Obsessive-compulsive Disorder
Oxytocin Administration in BDD and OCD
The purpose of the current study is to investigate the effect of an acute administration of intranasal oxytocin, relative to placebo, on social cognitive impairments among individuals with body dysmorphic disorder and…
- Trial name
- NCT02671266
- Testing
- Oxytocin
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Orthognathic Surgical Procedures, Psychiatric Disorders
Incidence of Body Dysmorphic Disorder (BDD) in a Population of Patients Undergoing Orthognathic Surgery
Assessment of the incidence of Body dismorphic disorder in a population candidated to orthognathic surgery
- Conditions
- Orthognathic Surgical Procedures, Psychiatric Disorders, Prognathism
- Trial name
- IBDOS (NCT06879275)
- Testing
- Questionnaire and Physical Exam
- Where
- Italy
- Volunteers
- 90 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Body Dysmorphic Disorders
Feasibility Pilot Study of Internet-based Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder With Global Recruitment
The aim of the study is to study an english-language version of BDD-NET (Enander, et al., 2014; Enander, et al., 2016), an internet-based treatment for Body Dysmorphic Disorder, on a globally recruited sample.
- Trial name
- BDD-G (NCT03517384)
- Testing
- I-CBT for Body Dysmorphic Disorder
- Where
- Sweden
- Volunteers
- 32 people
- Sponsor
- Karolinska Institutet
Body Dysmorphic Disorder, Steroid Abuse
CBT for Muscle Dysmorphia and Steroid Abuse: A Randomized Controlled Trial
The goal of this clinical trial is to evaluate the effectiveness of cognitive behavioral therapy (CBT) in treating muscle dysmorphia (MD) under body dysmorphic disorder (BDD) and steroid/performance-enhancing drug (PED) abuse in…
- Conditions
- Body Dysmorphic Disorder, Steroid Abuse, Body Dysmorphic Disorder (BDD), Subtype: Muscle Dysmorphia
- Trial name
- NCT06781853
- Testing
- Cognitive Behavioral Therapy (CBT)
- Where
- Turkey (Türkiye)
- Volunteers
- 71 people
- Sponsor
- Uskudar University
Obsessive-Compulsive Disorder, Illness Anxiety Disorder
Study of Dextromethorphan in OCD and Related Disorders
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
- Conditions
- Obsessive-Compulsive Disorder, Illness Anxiety Disorder, Body Dysmorphic Disorders, Somatic Symptom Disorder
- Trial name
- NCT04899687
- Testing
- Fluoxetine, Dextromethorphan
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Stanford University
Body Dysmorphic Disorder
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder.
- Trial name
- NCT01002326
- Testing
- Cognitive-Behavioral Therapy
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorders
Understanding Daily Changes in BDD Risk Using Smartphones
Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD.
- Trial name
- NCT04254575
- Testing
- None, observational study only (no interventions)
- Where
- United States
- Volunteers
- 87 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorders, Dysmorphophobia
Internet-delivered Cognitive-behaviour Therapy for Adolescents With Body Dysmorphic Disorder
The purpose of this trial is to investigate whether a therapist-guided Internet-delivered cognitive behaviour therapy (ICBT) programme is feasible for adolescents with body dysmorphic disorder (BDD).
- Trial name
- NCT05078320
- Testing
- Exposure and response prevention (ERP)
- Where
- Sweden
- Volunteers
- 20 people
- Sponsor
- Karolinska Institutet
Body Image Disorder, Body Dysmorphic Disorders
A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students
Body dissatisfaction represents a prevalent condition in young women, and it is associated with low self-esteem, depression, and symptoms of Body Dysmorphic Disorder (BDD) and Eating Disorders (EDs).
- Conditions
- Body Image Disorder, Body Dysmorphic Disorders, Eating Disorders
- Trial name
- NCT04103606
- Testing
- GGBI: Positive Body Image (Mobile App)
- Where
- Italy
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University of Padova
Body Dysmorphic Disorder
Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)
The aim of the research is to determine if Cognitive Behaviour Therapy (CBT) specific for BDD is more effective than a credible non-specific form of CBT for treating BDD and its delusional variant in adults aged 17 or over.
- Trial name
- NCT00871143
- Testing
- CBT specific for BDD, Non specific CBT
- Where
- United Kingdom
- Volunteers
- 46 people
- Sponsor
- Institute of Psychiatry, London
Plastic Surgery
Reduction Nymphoplasty: Assessment of the Impact on Sexuality, Self-Esteem and Screening for Dysmorphophobia
Reduction nymphoplasty is the treatment of benign hyperplasia of the labia minora. This surgery is indicated in the event of functional, aesthetic or sexual discomfort.
- Trial name
- NYRESED (NCT05900869)
- Testing
- FSFI, BES
- Where
- France
- Volunteers
- 28 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Body Image, Mental Health Outcomes
Overvaluation of Weight and Shape Intervention vs The Body Project
Priorities aims to reduce body image concerns, prevent eating disorders, bolster self-esteem, and promote mental and emotional health by helping participants identify and nurture alternative sources of self-worth.
- Conditions
- Body Image, Mental Health Outcomes, Eating Disorders, Body Dysmorphic Disorders
- Trial name
- NCT07678554
- Testing
- Priorities, Body Project
- Where
- United States
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Stanford University
Anxiety Disorders, Somatoform Disorders
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
This study's primary aim is to compare time to relapse and relapse rates in responders to acute escitalopram who are then randomized to placebo versus continuation treatment with escitalopram.
- Trial name
- NCT00149799
- Testing
- Escitalopram
- Where
- 2 sites in United States
- Volunteers
- 100 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorhpic Disorder
Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)
The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.
- Trial name
- NCT01850433
- Testing
- Internet based CBT for body dysmorphic disorder
- Where
- Sweden
- Volunteers
- 23 people
- Sponsor
- Karolinska Institutet
Body Dysmorphic Disorders
TMS Visual Modulation in Body Dysmorphic Disorder
The goal of this observational study is to test the effects of a type of noninvasive brain stimulation called transcranial magnetic stimulation (TMS) on visual processing in adults with body dysmorphic disorder symptoms when…
- Trial name
- EMPAC-BDD (NCT05607121)
- Testing
- intermittent theta burst stimulation, continuous theta burst stimulation
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- Centre for Addiction and Mental Health